awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35026567-ED4DB3CC-7FBB-4AD5-B6EB-F5290E9A4C0D
Q35026567-ED4DB3CC-7FBB-4AD5-B6EB-F5290E9A4C0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35026567-ED4DB3CC-7FBB-4AD5-B6EB-F5290E9A4C0D
Emerging agents to combat complicated and resistant infections: focus on ceftobiprole
P2860
Q35026567-ED4DB3CC-7FBB-4AD5-B6EB-F5290E9A4C0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35026567-ED4DB3CC-7FBB-4AD5-B6EB-F5290E9A4C0D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2bbb4595dc76496834392281e704d7e01b8bbae5
P2860
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.